Kotak Wealth Management:企業の戦略・SWOT・財務分析

◆英語タイトル:Kotak Wealth Management - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5266
◆発行会社(調査会社):MarketLine
◆発行日:2020年3月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥19,950見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥39,900見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥59,850見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Kotak Wealth Management – Strategy, SWOT and Corporate Finance Report
Summary

Kotak Wealth Management – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Kotak Wealth Management (Kotak Wealth) is a private banking service provider. The bank offers its solutions to high-net-worth individuals (HNWIs have a net worth of US$1.0 million or more, excluding their primary residence), and ultra-high-net-worth individuals (UHNWIs have a net worth of US$30 million or more, excluding their primary residence), wealthy families, employed professionals, business families, and entrepreneurs. Key services offered by the bank include traditional banking solutions, portfolio assessment, advisory and management solutions, wealth management research and solutions, transactional services and asset advisory and management solutions. It also offers estate planning, family office solutions, investment solutions, philanthropy solutions, tax solutions, investment solutions, and professional administration solutions. The bank’s investment threshold stands at INR50 million for asset advisory services, and INR1 billion for family office services. It is the private banking arm of Kotak Mahindra Bank Ltd., banking, insurance, and financial services provider based in India. Kotak Wealth is headquartered in Mumbai, India.

Scope

- Detailed information on Kotak Wealth Management required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Kotak Wealth Management in the form of a SWOT analysis
- An in-depth view of the business model of Kotak Wealth Management including a breakdown and examination of key business segments
- Intelligence on Kotak Wealth Management’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Kotak Wealth Management, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Kotak Wealth Management and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Kotak Wealth Management as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Kotak Wealth Management’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Kotak Wealth Management: Company Overview
Kotak Wealth Management: Overview and Key Facts
Kotak Wealth Management: Overview
Kotak Wealth Management: Key Facts
Kotak Wealth Management: Key Employees
Kotak Wealth Management: Key Employee Biographies
Kotak Wealth Management: Major Products and Services
Kotak Wealth Management: Company History
Kotak Wealth Management: Locations and Subsidiaries
Kotak Wealth Management: Key Competitors
Kotak Wealth Management: Company Analysis
Kotak Wealth Management: Business Description
Kotak Wealth Management: SWOT Analysis
Kotak Wealth Management: SWOT Overview
Kotak Wealth Management: Strengths
Kotak Wealth Management: Weaknesses
Kotak Wealth Management: Opportunities
Kotak Wealth Management: Threats
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Kotak Wealth Management: Key Facts
Table 2: Kotak Wealth Management: Key Employees
Table 3: Kotak Wealth Management: Company History
Table 4: Kotak Wealth Management: Locations and Subsidiaries
Table 5: Kotak Wealth Management: Key Competitors

★海外企業調査レポート[Kotak Wealth Management:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kowa Co Ltd (7807):企業の財務・戦略的SWOT分析
    Kowa Co Ltd (7807) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Oxford Biodynamics Plc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxford Biodynamics Plc (Oxford Biodynamics) is a developer of biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neu …
  • Kura Oncology Inc (KURA)-製薬・医療分野:企業M&A・提携分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company which discovers and develops therapeutics for the treatment of solid tumors and blood cancers. Its lead drug candidate, Tipifarnib, an inhibitor of protein farnesylation, is a small molecule that targets oncogene …
  • Syndax Pharmaceuticals Inc (SNDX)-医療機器分野:企業M&A・提携分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is aclinical stage biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate, entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for t …
  • Camden Property Trust:企業の戦略・SWOT・財務情報
    Camden Property Trust - Strategy, SWOT and Corporate Finance Report Summary Camden Property Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Kimball Electronics Inc (KE):企業の財務・戦略的SWOT分析
    Kimball Electronics Inc (KE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • AZTherapies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary AZTherapies Inc (AZTherapies) is a clinical-stage drug development company that offers discovery, development and commercialization of novel Alzheimer’s disease therapeutics. The company’s product pipeline includes the lead product candidate ALZT-OP1, besides ALZT-Patch, ALZT-QoL, AZHALER-D …
  • China Investment Corp:企業のM&A・事業提携・投資動向
    China Investment Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Investment Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Soft Tissue Regeneration Inc-医療機器分野:企業M&A・提携分析
    Summary Soft Tissue Regeneration Inc (STR) is a medical device company that develops technology for soft tissue regeneration of the anterior cruciate ligament of the knee. The company concentrates on the application of resorbable polymer scaffold technology to regenerate and repair ligament and tend …
  • Chaman Lal Setia Exports Ltd:企業の戦略・SWOT・財務分析
    Chaman Lal Setia Exports Ltd - Strategy, SWOT and Corporate Finance Report Summary Chaman Lal Setia Exports Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Bechtel Corp:企業の戦略的SWOT分析
    Bechtel Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Optus Inc:企業の戦略的SWOT分析
    Optus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • XPO Logistics, Inc.:企業のM&A・事業提携・投資動向
    XPO Logistics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's XPO Logistics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Suzlon Energy Ltd (SUZLON):企業の財務・戦略的SWOT分析
    Suzlon Energy Ltd (SUZLON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Skanska AB (SKA B):企業の財務・戦略的SWOT分析
    Skanska AB (SKA B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Carr’s Group Plc (CARR):企業の財務・戦略的SWOT分析
    Carr's Group Plc (CARR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Repsol SA Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Repsol SA Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Repsol SA (Repsol) is an integrated oil and gas company. It has presence across the entire value chain: exploration and production, transformation, development and marketing of energy. The company’s upstre …
  • IHI Corporation (7013)-エネルギー分野:企業M&A・提携分析
    Summary IHI Corporation (IHI) is a heavy machinery engineering group. It provides technology oriented products and services to customers in the public, private and industrial sectors across the world. The group designs and manufactures a diverse range of products including ships and offshore facilit …
  • Abionic SA:医療機器:M&Aディール及び事業提携情報
    Summary Abionic SA (Abionic) is a medical device company that develops, produces, and markets in vitro diagnostic devices. The company provides products such as abioSCOPE, IVD capsule, abioGUIDE, abioGUIDE application for android, iPhone and iPad, and accessories, among others. Its abioSCOPE in vitr …
  • AcuFocus Inc-医療機器分野:企業M&A・提携分析
    Summary AcuFocus Inc (AcuFocus) is a medical device company that develops and markets technologies for the improvement of near vision. The company's products include kamra inlay, small aperture lens and acutarget HD instrument. It offers near vision solutions and develops ophthalmic medical devices. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆